In parts one and two of this series, we looked at how we responded to the unprecedented challenges the COVID-19 pandemic and the lessons...

In parts one and two of this series, we looked at how we responded to the unprecedented challenges the COVID-19 pandemic and the lessons...

In part one of this series, we explored as an introduction how we initially responded to the Covid-19 pandemic to move faster in the...

In part one of this series, we explored as an introduction how we initially responded to the Covid-19 pandemic to move faster in the...

New GMP requirements from 31 January 2022 Monday 31 January 2022 saw the Clinical Trial regulation (CTR) come into force in the European...

New GMP requirements from 31 January 2022 Monday 31 January 2022 saw the Clinical Trial regulation (CTR) come into force in the European...

The Covid-19 pandemic has been a challenging time for all of us and in this three-part blog series, we reflect on what we have learnt and...

The Covid-19 pandemic has been a challenging time for all of us and in this three-part blog series, we reflect on what we have learnt and...

The MHRA has launched an  8-week public consultation on proposals for legislative changes for clinical trials. Following the UK’s exit...

The MHRA has launched an  8-week public consultation on proposals for legislative changes for clinical trials. Following the UK’s exit...

The MHRA GPvP Inspection Metrics report for the period April 2020 to March 2021 is now available. Read the full metrics report published...

The MHRA GPvP Inspection Metrics report for the period April 2020 to March 2021 is now available. Read the full metrics report published...

In August 2020 the International Coalition of Medicines Regulatory Authorities (ICMRA) established a working group to look at the move to...

In August 2020 the International Coalition of Medicines Regulatory Authorities (ICMRA) established a working group to look at the move to...

On 13 August 2021, the Medicines & Healthcare products Regulatory Agency (MHRA) held a webinar to provide information and guidance around...

On 13 August 2021, the Medicines & Healthcare products Regulatory Agency (MHRA) held a webinar to provide information and guidance around...

The MHRA published the GXP Data Integrity Guidance in March 2018 (see https://mhrainspectorate.blog.gov.uk/2018/03/09/mhras-gxp-data-inte...

The MHRA published the GXP Data Integrity Guidance in March 2018 (see https://mhrainspectorate.blog.gov.uk/2018/03/09/mhras-gxp-data-inte...

MHRA, US-FDA and Health Canada colleagues at the London 2020 GCP symposium The second Medicines and Healthcare products Regulatory Agency...

MHRA, US-FDA and Health Canada colleagues at the London 2020 GCP symposium The second Medicines and Healthcare products Regulatory Agency...